Acquired resistance to ancrod. Its evaluation and clinical occurrence.
D000328:Adult; D000347:Afibrinogenemia / Q000139:chemically induced; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000378:metabolism; D000997:Antivenins; D001777:Blood Coagulation; D004341:Drug Evaluation; D004351:Drug Resistance; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis; D005500:Follow-Up Studies; D006168:Guinea Pigs; D006490:Hemostatics / Q000097:blood*; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000097:blood*; D011485:Protein Binding; D011817:Rabbits; D012911:Snakes; D013997:Time Factors; D014688:Venoms
D000925:Anticoagulants; D000997:Antivenins; D006490:Hemostatics; D014688:Venoms; D005340:Fibrinogen; D010447:Peptide Hydrolases